Ground Truth
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.comInclusion Criteria:Newly Diagnosed Acute Myeloid Leukemia (AML)Considered inappropriate for intensive remission induction therapy by an investigatorNot eligible for stem cell transplantationExclusion Criteria:Acute promyelocytic leukemiaCurrent Myelodysplastic syndrome only subjectsOther protocol defined inclusion/exclusion criteria could apply
Prediction
For more information regarding BMS clinical trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
- AML
- Considered inappropriate for intensive remission induction therapy by an investigator
- Not eligible for stem cell transplantation
Exclusion Criteria:
- Acute promyelocytic leukemia
- Myelodysplastic syndrome only subjects
Note: The exclusion criteria was revised to specify allogeneic transplants in patients who received prior hematopoietic stem cell transplantation.